Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2011; Volume 203, Supplement 688
The 62nd National Congress of the Italian Physiological Society
9/25/2011-9/27/2011
Sorrento, Italy


LEPTIN AS A NEW NEUROPROTECTIVE DRUG FROM HYPOXIC INJURY IN THE HIPPOCAMPUS: A MEA STUDY
Abstract number: P106

GAVELLO1 D, CARABELLI1 V, CARBONE1 E

1Dept Neuroscience, Univ. of Torino, Italy

The hippocampus is a key brain region involved in synaptic plasticity, learning, memory formation, and neurodegenerative disorders such as Alzheimer's disease (AD). Leptin has been recently shown to affect neuronal activity and neuronal survival, thanks to its neurotrophic action. Here we report the effect of hypoxia (3% O2, 2 hours), on the firing pattern of mouse hippocampal primary cultures in the presence and the absence of leptin. The tool used in this study is the Multi Electrode Array (MEA) that allows monitoring the electrical activity of cultured neuronal network. Under normoxic conditions we found that the firing frequency and the number of bursts increased between 11 and 18 DIV. The former increased from 0.8 to 1.8 Hz while the latter from 6.5 to 10 (over 90 seconds recordings), suggesting that in elder cultures, events predominantly occurred during synchronized patterns of activity. Exposure to hypoxic conditions caused a significant reduction of the firing frequency, by 51 ± 3% and 71 ± 2% respectively at 11 and 18 DIV, which was reversed when returning to normoxia. When hippocampal neurons were pre-treated with leptin (50 nM) 1 hour before their exposure to hypoxic conditions, the firing frequency was reduced by only 52 ± 2% at 18 DIV and 49 ± 4% at 11 DIV, suggesting that 50 nM leptin exerts a preferential cytoprotective effect on elder hippocampal neurons (18 DIV) subjected to hypoxic injury.

To cite this abstract, please use the following information:
Acta Physiologica 2011; Volume 203, Supplement 688 :P106

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE